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1. PREFACE 
Since the first hypervalent organoiodine reagent, (dichloroiodo)benzene, was 
synthesized in 1886, those compounds have increasingly gained more and more attention 
in organic chemistry due to their synthetic versatility. Moreover, their similarity in 
reactivity to transition metal complexes made these hypervalent organoiodine compounds 
preferred as green alternatives to limit the negative impact on the environment. In 
addition to well-known commercially available hypervalent iodine compounds such as 
DIB, PIFA, HTIB (Koser’s reagent), DMP, and IBX, hundreds of other hypervalent 
iodine compounds have been continuously studied in the scope of preparation, structural 
and property determination, and reactivity as reagents or catalysts in various 
transformations such as halogenation, oxidation and oxidative functionalization, 
azidation, amination, rearrangement, etc. As a part of our ongoing research of finding 
new hypervalent organoiodine reagents, we studied the reactivity of 2-
[hydroxy(trifluoromethanesufonyloxy)]iodobenzoic acid (IBA-OTf) in the oxidative 
cycloaddition of benzaldoximes with acetonitrile and maleimide to prepare substituted 
1,2,4-oxadiazoles and bicyclic isoxazolines, respectively. The reactions were performed 
in the catalytic manner where IBA-OTf can be generated in situ from a small amount of 
2-iodobenzoic acid (5-10 mol %). However, the isolated yields of investigated products 
were comparable with those obtained using a stoichiometric amount IBA-OTf as reported 
previously. 
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2. BACKGROUNDS 
2.1. General information on iodine and its common applications 
Elemental iodine was first isolated in 1811 from seaweed ashes by French chemist 
Bernard Courtois. Since then, iodine compounds have found numerous applications in 
many fields, especially in medicine and pharmaceuticals. For example, potassium iodide 
is used to treat acute thyrotoxicosis as well as to limit the radioactive exposure of iodine-
131 from nuclear crises or radiopharmaceutical therapy. Due to its strong interaction with 
X-ray, many iodine-based X-ray contrast agents were also developed and have been used 
commonly in medicine to enable the visualization of soft tissues in X-ray imaging. The 
solution of elemental iodine and potassium iodide in alcohol is well known for its 
antimicrobial activity. Other applications include the using of copper iodide as stabilizer 
for thermoplastic nylon production, rhodium- and iridium iodide complexes as the 
catalysts for the industrial scale manufacture of acetic acid, polyiodides incorporated into 
polyvinyl alcohol as polarizing film for LCD screens, and iodine-based biocides as 
additives to cosmetics, paints, inks, wood, etc. for preservation purpose.1-4 In organic 
chemistry, elemental iodine as well as iodide compounds have also gained numerous 
applications, mainly as catalysts and pre-catalysts for various oxidative transformations. 
Their activity in some way resembles that of transition-metallic catalysts. However, non-
toxic property and inexpensive source of supply of iodine-based catalysts have made 
them increasingly favorable from the viewpoint of sustainable chemistry.5, 6 
 
Figure 1. The usage of iodine in different fields.4 
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2.2. General information on hypervalent iodine compounds 
2.2.1. Definition, classification, and geometry 
According to IUPAC, hypervalency is the ability of an atom in a molecular entity to 
expand its valence shell beyond the limits of the Lewis octet rule. Hypervalent 
compounds are common for the second and subsequent row elements in groups 15–18 of 
the periodic table.7 Among these, hypervalent iodine compounds have gained much 
attention due to their versatility in organic syntheses. Fundamentally, they can be used as 
substrates, reactants, reagents, or catalysts for various organic reactions, such as 
halogenation, oxidation and oxidative functionalization, azidation, amination, 
rearrangement, etc.2 
In general, hypervalent iodine compounds are classified into seven types whose 
structures are shown in Figure 2. Species 1, iodonium salts, in some aspects, can be 
commonly considered as trivalent iodine compounds when the presence of a loose 
coordination bond between the central iodine atom and the counter anion was confirmed 
by X-ray crystallography. Therefore, together, species 1-3 are placed into the same group 
of trivalent iodine (iodinanes) in which the oxidation state of central iodine atom is +3. 
Species 4 and 5 whose central iodines have the oxidation state of +5 are classified as 
pentavalent iodines (periodinanes). A large variety of trivalent and pentavalent 
organoiodine compounds have been successfully prepared, characterized, and tested for 
their application in organic synthesis (Figure 3). Meanwhile, for heptavalent iodine 
species 6 and 7, there have been only several inorganic compounds of iodine (VII) 
reported, such as IF7, IO2F3, IOF5, and the derivatives of HIO4.
2 
 
Figure 2. Martin-Arduengo classification of hypervalent iodine species.2 
Depending on the oxidation state of the iodine center and the number of ligands 
surrounding it, the geometry of hypervalent iodine compounds can be various. Trivalent 
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iodine compounds ArIL2 have trigonal bipyramidal geometry with sp
2-hybridized iodines 
at the center. Two lone pairs of electrons and the aryl substituent occupy equatorial 
positions while two heteroatomic ligands L are located at apical positions. The 
overlapping between two ligand orbitals and a filled 5p orbital of central iodine 
establishes a linear three-center four-electron hypervalent bond consisting three new 
molecular orbitals: bonding, nonbonding, and antibonding. The presence of a node at 
central iodine in the nonbonding molecular orbital make the hypervalent bond more 
polarized, longer and weaker than a normal covalent bond. As a result, two apical ligands 
are relatively labile, making the electron-deficient iodine center more susceptible to 
nucleophilic attack by various substrates to finally afford corresponding oxidative 
products after further consecutive steps.  
 
Figure 3. Bonding in trivalent and pentavalent iodine compounds and the molecular orbital 
description of a hypervalent bond. 
In a similar way, the molecular geometry of iodonium salts (typically Ar2IX) was also 
identified as a distorted pseudo-trigonal bipyramid by single X-ray crystallographic 
studies when associated anions were found to be able to bond loosely to iodine atom. 
Meanwhile, the onium salts of other elements from the second and the third rows of the 
periodic table, such as ammonium, oxonium, phosphonium, and sulfonium salts, most 
likely exist in tetrahedral geometry. 
5 
 
The bonding in pentavalent iodine compounds ArIL4 takes the shape of square 
bipyramid in which one sp-hybridized orbital of the central iodine is used to make a bond 
with the aryl moiety, and four heteroatomic ligands are distributed on two perpendicular 
3c-4e hypervalent bonds.  
2.2.2. Common classes of hypervalent organoiodine compounds 
Trivalent iodine compounds are most commonly studied for their preparation, 
structure and synthetic applications with a large number of representatives being 
commercially available.  Iodosylarenes, [bis(acyloxy)iodo]arenes, and 
[hydroxy(sulfonyloxy)iodo]arenes are generally used as the reagents for oxidation as well 
as oxidative functionalization of various organic substrates. Some important 
representatives of [bis(acyloxy)iodo]arenes and [hydroxy(sulfonyloxy)iodo]arenes are 
commonly commercially available, such as DIB, PIFA, and Koser’s reagent. Meanwhile, 
the typical iodosylarene derivative, iodosylbenzene, is mainly prepared in laboratory 
scale for very few studies on the synthetic application due to its extremely poor solubility 
in most common organic solvents except for methanol and DMSO. (Difluoroiodo)arenes 
and (dichloroiodo)arenes are used as fluorinating and chlorinating reagents, 
respectively.8, 9 
Cyclic trivalent iodine compounds exhibited better stability than their acyclic 
analogues due to the effective overlapping of two sp2-hybridized lone pairs of electrons 
in iodine center with the π-electron system in the aromatic ring. Among a large variety of 
cyclic trivalent iodine compounds, benziodoxes have gained a lot of interest in organic 
synthesis as versatile reagents for multiple oxidative functionalizations of various 
substrates in which the heteroatomic ligands are transferred from trivalent iodine species 
to organic substrates.8, 9 
Iodonium salts, in general, react with organic substrates in an entirely different way 
compared to the above listed trivalent iodine reagents. They have found broad application 
in alkylation, alkenylation, alkynylation, and arylation of various organic and inorganic 
substrates in a mild and highly selective manner. Specifically, iodonium ylides and 
iodonium imides are considered as excellent carbene and nitrene precursors, 
respectively.8,10 
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Compared with trivalent iodine compounds, pentavalent iodine compounds are less 
common in terms of the number of synthesized reagents. The typical noncyclic 
iodylbenzene can be used as an oxidizing reagent in spite of its explosive nature at 
elevated temperature and poor solubility in most common organic solvents. These 
drawbacks are also noted for IBX while moisture sensitivity is the major problem for the 
storage of DMP. Similar the other hypervalent iodine reagents, IBX and DMP along with 
their derivatives have also found much application in a variety of organic oxidative 
transformations.9, 11 
 
Figure 4. Common classes of hypervalent organoiodine compounds.9 
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2.3. Trivalent iodine reagent-mediated cycloadditions 
2.3.1. Cycloaddition via benzyne intermediate 
Due to its instability, benzyne can be only generated in situ according to some 
common methods depicted in Scheme 1. The generation of benzyne by treatment of an 
aryl halide with a strong base suffers an unavoidable drawback where the strong base can 
compete against nucleophiles in the reaction with benzyne. This advantage can be 
overcome by the treatment of o-dihalosubstituted benzene with an active metal (lithium 
or magnesium) to produce the desired benzyne after the elimination. Benzynes may also 
be obtained in high yields from the precursors such as 1-aminobenzotriazole, anthranilic 
acid, and 1,2,3-benzothiadiazole 1,1-dioxide. However, these methods are unfavorable 
from the viewpoint of safety because of their explosive nature. The Kobayashi protocol, 
in which benzynes are generated from 2-(trimethylsilyl)phenyl triflates under mild 
condition (at ambient temperature in neutral medium), has been considered as an 
alternative to afford benzynes in good yields.12 
 
Scheme 1. General methods for the preparation of benzynes.12 
Similarly, [2-(trimethylsilyl)phenyl]iodonium triflates can also generate benzyne 
intermediates quantitatively under mild conditions. Therefore, in comparison with 
previous methods (treating aryl halides with strong bases or using potentially explosive 
precursors such as arenediazonium-2-carboxylates, 1-aminobenzotriazole, and 1,2,3-
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benzothiadiazole 1,1-dioxide), this method provided a more convenient way to generate 
benzyne in a manner where side reactions (addition to anions or dimerization) were 
limited, and safety issues were resolved. 
 
Scheme 2. Synthesis of [2-(trimethylsilyl)phenyl]iodonium triflates and its application in 
cycloaddition via benzyne intermediate.13, 14 
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Kitamura et al. studied the cycloaddition of benzyne generated in situ by a simple 
treatment of [2-(trimethylsilyl)phenyl](phenyl)iodonium triflate or [2-
(hydroxydimethylsilyl)phenyl](phenyl)iodonium triflate with Bu4NF in the presence of 
various trapping agents (Scheme 2). All the reactions were conducted at room 
temperature within a short time from 20 to 30 min to afford the corresponding 
heterocyclic products in good yields (72-98%). The hypervalent iodine reagent can be 
obtained from 1,2-dibromobenzene through a three-step protocol in the total yield of 
68%.13, 14 
The reaction scope of this method was also broadened to benzyne precursors bearing 
reactive functional groups which are not tolerable under harsh conditions in other 
methods. Specifically, the treatment of [5-acyl-2-(trimethylsilyl)phenyl]iodonium triflates 
with BuNF4 in the presence of trapping agent furan afforded the desired cycloadducts in 
good yields (74-94%).15 
 
Scheme 3. Generation of acylbenzynes from hypervalent iodine compounds and their 
cycloaddition with furan.15 
Interestingly, bis-heterocyclic compounds were also successfully synthesized from 
1,2,4,5-tetrakis(trimethylsilyl)benzene via two benzyne intermediates. The triazole or 
diazole moiety was first incorporated into the benzene ring by 1,3-dipolar cycloaddition 
to produce benzotriazole and indazole, respectively, which then further converted into 
bis-heterocyclic compounds by another benzyne-mediated cycloaddition to furan.16 
Recently, Stuart et al. demonstrated the reactivity of various unsymmetrical 
aryl(mesityl)iodonium salts towards Diels-Alder cycloaddition with furan. As expected, 
10 
 
the reactions proceeded via the reactive benzynes which were generated in situ from the 
corresponding iodonium salts under the presence of a stoichiometric quantity of 
LiHMDS.17 
 
Scheme 4. Multistep process for the preparation of bi-heterocyclic compounds via benzyne-
mediated cycloadditions.16 
 
Scheme 5. Diels-Alder cycloaddition of unsymmetrical aryl(mesityl)iodonium salts with furan 
via benzyne intermediates.17 
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2.3.2. Cycloaddition via nitrile oxide intermediate 
2.3.2.1. Common methods for nitrile oxide preparation  
 From aldoxime 
Under some circumstances, nitrile oxides can be easily generated from the 
corresponding aldoxime through direct oxidation or consecutive halogenation-
dehydrohalogenation process via the intermediate hydroxymoyl halides. For the direct 
oxidation, some trivalent iodine compounds were reported as oxidants which can 
efficiently convert aromatic aldoximes into the corresponding nitrile oxides. 
Hydroximoyl halides, typically hydroximoyl chlorides, can be obtained from 
aldoximes under the presence of chlorine-containing oxidants such as N-
chlorosuccinimide, t-BuOCl, and NaOCl. The subsequent dehydrochlorination in a basic 
medium affords the desired nitrile oxides.18, 19 
 
Scheme 6. Generation of nitrile oxides from aldoximes and hydroximoyl chlorides. 
 From nitro compounds 
Generally, nitrile oxides can also be obtained by the dehydration of primary aliphatic 
nitro compounds according to the Mukaiyama procedure in the presence of aryl 
isocyanate and Et3N as the reagent and the catalyst, respectively. Various other reagents, 
such as POCl3, AcCl, Ac2O, BzCl, SOCl2/Et3N, and MeSO2Cl, were also tested for the 
dehydration of nitroalkanes.18, 19 
 
Scheme 7. Generation of nitrile oxides from primary nitro compounds.18 
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 From furoxans – the dimerization form of nitrile oxides 
Some stable commercially available furoxans are considered as the starting materials 
for generating unstable nitrile oxides by thermolysis or photolysis. In the presence of 
trapping agents, further reactions will proceed, such as cycloaddition with trapping agents 
or conversion to bisisocyanate. Not only furoxans but also other five-membered 
heterocycles including isoxazolines, 1,2,4-oxadiazoles, and furazans can be used for the 
cycloreversion to generate nitrile oxides.18, 19 
 
Scheme 8. Generation of nitrile oxides from furoxan by cycloreversion.19 
2.3.2.2. Hypervalent iodine compounds as the reagents for generating nitrile 
oxides  
2.3.2.2.1. Intramolecular cycloaddition via nitrile oxides 
In 2005, Bandgar et al. reported the formation of benzopyrano- and furopyrano-2-
isoxazolines through the intramolecular 1,3-dipolar cycloaddition of 2-
allyloxybenzaldoximes and 3-O-allyl-1,2-isopropylidene-furanose-5-aldoximes, 
respectively, in the presence of DIB in CH2Cl2. All the reactions were carried at 0 
oC to 
room temperature within 1 h to afford the desired product in high isolated yield from 74 
to 90%.20 
 
Scheme 9. The DIB-mediated formation of benzopyrano- and furopyrano-2-isoxazolines.20 
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Scheme 10. The proposed mechanism for intramolecular cycloaddition 2-
allyloxybenzaldoximes.20 
The oxidative activity of DIB towards intramolecular 1,3-dipolar cycloaddition was 
also tested using polar solvents such as MeOH and MeCN in the presence of catalytic 
amount of TFA. The reaction scope was expanded to various aldoximes. Remarkably, the 
oxidative dearomatization of aldoximes bearing phenolic moieties was also recorded.21 
 
Scheme 11. The DIB-mediated intramolecular cycloadditions in catalytic TFA/MeOH.21 
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Scheme 12. Tandem oxidative methoxylation and oxidative amidation under the presence of 
DIB.21 
Interestingly, the pentacyclic core structure of cortistatins - a group of biologically 
active steroidal alkaloids isolated from the Indonesian marine sponge Corticium simplex - 
was stereoselectively synthesized through a multistep process in which the tandem 
oxidative dearomatization/intramolecular 1,3-dipolar cycloaddition was considered as a 
keystone reaction. DIB was again used as an oxidative reagent to induce the generation of 
nitrile oxide.22 
 
Scheme 13. The hypervalent iodine-mediated synthesis of the pentacyclic core structure of 
cortistatins.22 
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2.3.2.2.2. Cycloaddition with alkynes 
In 2011, Jawalekar et al. reported a mild procedure to prepare various substituted 
isoxazoles by cycloaddition between terminal alkynes and nitrile oxides which are 
generated in situ from corresponding aldoximes in the presence of PIFA as an oxidant. 
The reactions were performed in MeOH/H2O at room temperature to give various di-
substituted isoxazoles with the yield ranging from 10 to 94%. Remarkably, there was no 
competitive cycloaddition of nitrile oxides to olefins in case of trans-cinnamaldoxime.23 
 
Scheme 14. The PIFA-induced cycloaddition of terminal alkynes and in situ nitrile oxides.23 
This protocol was also feasible for the cycloaddition of nitrile oxides to unprotected 
nucleosides and peptides bearing terminal alkyne group. The reaction, therefore, was 
believed to be tolerable towards various sensitive functional groups (-OH and -NH2). 
Koser’s reagent was also studied for its activity in the cycloaddition of aromatic 
nitrile oxides to various alkynes. Although the reactions were carried out at an elevated 
temperature of 80 oC, only moderate yields of the corresponding isoxazoles were 
recorded for aldoximes bearing electron-withdrawing substituents. Meanwhile, weak 
reactivity was observed for the aldoximes bearing electron-donating substituents when no 
product or only negligible yields of desired isoxazoles were reported.24 
Yoshimura et al. reported the cycloaddition of aromatic and aliphatic terminal 
alkynes to nitrile oxides generated by the action of hydroxy(aryl)iodonium ion under 
catalytic conditions. This activated hypervalent iodine species was generated in situ by 
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means of the reaction between an excess amount of oxone with a catalytic amount of 3,5-
dimethyliodobenzene.25 
 
Scheme 15. Koser’s reagent-mediated synthesis of substituted isoxazoles via cycloaddition of 
alkynes to nitrile oxides.24 
 
Scheme 16. Catalytic cycloaddition of aldoximes to alkynes in the presence of in situ hypervalent 
iodine species.25 
In 2016, Peddinti and co-workers developed a synthetic strategy of using oxidative 
reagent DIB to induce the formation of di- and tri-substituted isoxazoles via [3+2] 
cycloaddition of nitrile oxides to alkynes bearing electron-withdrawing groups. Various 
aromatic aldoximes including benzaldehyde oxime as well as its derivatives and 1-
naphthaldehyde oxime were investigated for the reactivity towards cycloaddition with 
three different alkynes to afford 24 isoxazoles in total after 10-15 mins of stirring at 0 
oC.26 
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Scheme 17. DIB-mediated formation of di- and tri-substituted isoxazoles via [3+2] cycloaddition 
of nitrile oxides.26 
2.3.2.2.3. Cycloaddition with alkenes 
The hypervalent iodine-mediated formation of isoxazolines as well as other 
heterocyclic compounds from aromatic aldoximes was first described by Takana and co-
workers in 2002. In this research, iodosylbenzene (PhIO) was employed as an oxidative 
reagent to convert benzaldoxime in the presence of different dipolarophiles into 
corresponding oxidative cyclization products in fair to good yields for most cases. 
Without any trapping reagent, the nitrile oxide generated from benzaldoxime expectedly 
undergoes dimerization to give furoxan in almost quantitative yields. 
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Scheme 18. Iodosylbenzene-mediated cyclization of benzaldoxime with different 
dipolarophiles.27 
An alternative method to achieve the formation of isoxazolines from aromatic 
aldoximes and activated alkenes was then also reported by Reddy and co-workers in 
2004. According to this procedure, an excess amount DIB was required to induce the 
quantitative in situ generation of nitrile oxides from aldoximes at mild conditions (0 oC - 
rt within 1 - 1.5 h). A consecutive cyclization step of reactive nitrile oxides with different 
activated olefins afforded various substituted isoxazolines in excellent isolated yields up 
to 90%. This method was also applicable for the preparation of isoxazolines derived from 
Baylis-Hillman adducts which are considered as important precursors to synthesize 
various bioactive compounds.28 
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Scheme 19. The reaction scope and mechanism of DIB-mediated formation of isoxazolines.28 
In 2009, Ciufolini et al. also reported the methodology to obtain substituted 
isoxazolines from aldoximes via the intermediate nitrile oxides generated in the presence 
of DIB. The optimization study was conducted in different solvents including CHCl3, 
THF, TFE, HFIP, MeOH, and MeCN at room temperature. As the result, MeOH in 
combination with a small amount of TFA acting as an effective Brønsted acid promoter 
was the best solvent system. The reaction scope was investigated on both aromatic and 
aliphatic aldoximes with different trapping olefins to give various isoxazolines in good 
yields from 63 to 95%.21 
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Scheme 20. DIB-mediated cycloaddition of alkenes to nitrile oxides.21 
In another research published in 2011, Ciufolini and co-workers expanded the 
substrate scope to α-oxo-aldoximes and α-oxo-ketoximes for cycloaddition to alkenes. 
Each kind of oximes was oxidized in a different way by DIB to generate various nitrile 
oxides which were subsequently trapped with norbornene or styrene to form the final 
cycloadducts. The nitrile oxides deriving from α-oxo-ketoximes were obtained via the 
oxidative cleavage of the carbonyl-imino σ bond which simultaneously converted the 
carbonyl moieties into methyl ester groups under the presence of solvent methanol. 
Meanwhile, the carbonyl moieties in nitrile oxides generated from α-oxo-aldoximes were 
kept unchanged.29 
The reactivity of α,α’-dioxo-ketoximes was also tested under the same reaction 
conditions. It was noted that the corresponding isoxazolines were formed in much lower 
yields than those deriving from mono-oxo homologues. It seemed likely that the presence 
of two carbonyl groups adjacent to the oxime group can diminish the nucleophilicity of 
the OH moiety by inductive and resonance electron-withdrawing effects as well as 
considerably prevent the OH group from cycloaddition to alkenes.29 
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Scheme 21. DIB-mediated cycloaddition of poor substrates α,α’-dioxo-ketoximes.29 
The oxidative performance of DIB on the dearomatization/cycloaddition of nitrile 
oxides to fullerene C60 was also studied. The cycloadducts, however, were only isolated 
in moderate yields (37-51%) in case of aromatic aldoximes. Even lower yields (15-28%) 
were observed for aliphatic or heterocyclic aldoximes.30 
 
Scheme 22. DIB-mediated consecutive dearomatization/cycloaddition of nitrile oxides to 
fullerene C60.
30 
In 2011, it was reported by Savage et al. that DIB exhibited a good tolerance towards 
aldoximes possessing boronate ester functional groups. The consecutive oxidation and 
cycloaddition were conducted at 0 oC in MeOH, to which a small amount (three drops) of 
TFA was added. All cycloadducts in which the boronate moieties were kept untouched 
were formed in varying yields ranging from 36% to 82%.31 
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Scheme 23. Cycloaddition of 4-pinacolatoboron benzonitrile oxide with different alkenes.31 
In previous publications, not much hypervalent iodine-mediated cycloaddition of 
heterocyclic aldoximes were reported.  To fulfill this vacancy, Prakash’s research group 
developed a procedure in which DIB was used as the oxidant to induce the cycloaddition 
of pyrazolyl aldoximes to activated alkenes bearing electron-withdrawing groups. All 
pyrazole-isoxazoline bis-heterocyclic compounds were obtained in high isolated yields 
from 82% to 92%.32 
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Scheme 24. DIB-mediated synthesis of pyrazolyl isoxazolines.32 
In the absence of dipolarophiles, the nitrile oxides derived from pyrazolyl aldoximes 
easily underwent the dimerization to corresponding 3,4-bis(pyrazolyl)-1,2,5-oxadiazole-
N-oxides in fair isolated yields (65-79%).33 
 
Scheme 25. The DIB-mediated dimerization of pyrazolyl aldoximes.33 
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In 2013, Yoshimura et al. reported the efficacy of using in situ generated 
hydroxyl(phenyl)iodonium ion as the oxidant for the consecutive oxidation/cycloaddition 
of aldoximes with olefins. This activated hypervalent iodine species was obtained by the 
oxidation of corresponding iodobenzene by oxone. Interestingly, it was generated in a 
catalytic amount, consumed in the oxidation of aldoximes to release nitrile oxides, and 
then regenerated for the next catalytic cycles throughout the reaction time. From the 
optimization study, it was shown that the combination of 3,5-dimethyliodobenzene and 
oxone in the solvent system MeOH/HFIP/H2O (10:10:1) gave the desired cycloadduct in 
the best yield. The reaction scope was studied for 11 olefins and 4 aldoximes under 
optimized conditions to prepare 16 different isoxazolines.25 
 
Scheme 26. Hypervalent iodine catalyzed cycloaddition of alkenes to nitrile oxides.25 
The mechanism for the catalytic cycloaddition, as proposed in this paper, consisted of 
several consecutive steps, among which the ligand exchange between aldoximes and 
active hypervalent iodine species is required for the formation of nitrile oxides. Two 
control experiments were also performed to confirm the existence of ligand exchange 
step and nitrile oxide formation.25 
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Scheme 27. Hypervalent iodine catalyzed cycloaddition of alkenes to nitrile oxides.25 
Interestingly, as a part of the same research of consecutive oxidation/cycloaddition of 
aldoximes with olefins, Yoshimura and co-workers reported a more effective procedure 
in which KI, a cheap iodine source, instead of 3,5-dimethyliodobenzene was employed as 
the pre-catalyst whose loading was only 10 mol %. As expected, the investigated 
isoxazolines were formed in comparable yields to the analogues obtained in the 
procedure of using 3,5-dimethyliodobenzene as the pre-catalyst. Proposed mechanism 
showed that the reaction undergoes the formation of cyclic iodonium ylides instead of 
nitrile oxides as the reactive intermediates with the assistance of in situ generated 
hypoiodous acid.34 
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Scheme 28. The substrate scope and reaction mechanism of the KI-Oxone assisted formation of 
isoxazolines.34 
Another catalytic protocol for the synthesis of isoxazolines from the cycloaddition of 
alkenes to nitrile oxides was developed by Yan’s group in 2014. In their research, the 
active trivalent iodine species was generated in situ in catalytic amount from the 
oxidation of iodobenzene by m-CPBA. Remarkably, aldehydes instead of aldoximes were 
used as the starting materials to prepare isoxazolines following a convenient one-pot 
synthesis consisting of the preparation of aldoximes, oxidation of resulted aldoximes into 
nitrile oxides, and finally cycloaddition of nitrile oxides to alkenes. All investigated 
aromatic aldehydes reacted with various olefins to afford the desired isoxazolines in good 
yields for most cases. On the contrary, aliphatic aldehydes was significantly less reactive 
towards cycloaddition when a low yield of 36% was reported for the cycloadduct 
deriving from phenylacetaldehyde and no product was detected for propanal.35 
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Scheme 29. One-pot synthesis of isoxazolines from aldehydes catalyzed by iodobenzene.35 
 
Scheme 30. Proposed mechanism for the iodobenzene-mediated one-pot synthesis of 
isoxazolines.35 
In another publication in the same year, Yan and co-workers also reported a similar 
catalytic protocol in which aldoximes were used directly as the starting materials. The 
reaction scope was studied on the same olefinic reactants to give the same isoxazolines in 
similar isolated yields. Again, the poor reactivity of phenylacetaldoxime, an aliphatic 
aldoxime, towards cycloaddition was confirmed when no desired product was detected.36 
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Scheme 31. Catalytic cyclization of aldoximes with alkenes under the assistance of in situ 
generated trivalent iodine species.36 
The activity of DIB was also studied on the [3+2] cyclization for one-pot synthesis of 
benzo[d]isoxazole-4,7-diols in aqueous medium. As noted from the mechanism depicted 
in Scheme 32, the reaction goes through the p-benzoquinone adducts which was then 
converted to benzo[d]isoxazole-4,7-diols after the treatment with Na2S2O3. The formation 
of two isomeric products can be observed for phenols bearing different substituents at 
ortho- and meta-positions (R1 ≠ R2). Interestingly, the wide synthetic applicability of this 
reaction was also testified by the preparation of more complex molecules such as 
isoxazolo[5,4-a]phenazines, indazole-4,7-diols, and benzodiisoxazole-4,8-diols in 
moderate to fair isolated yields.37 
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Scheme 32. The one-pot cyclization and reduction procedure for the synthesis of 
benzo[d]isoxazole-4,7-diols.37 
 
Scheme 33. The mechanism for DIB-assisted formation of benzo[d]isoxazole-4,7-diols.37 
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2.3.3. Other cycloadditions 
In 2014, Antonchick and co-workers developed a transition metal-free method to 
achieve isoquinolones by the oxidative annulation of N-protected benzamide with 
alkynes. The reactions were performed under the catalysis of DIB generated in situ from 
iodobenzene and peracetic acid in solvent HFIP at room temperature to afford 19 N-
protected isoquinolones in varying yields from 46% to 85%. A deprotection protocol of a 
typical cycloadduct was subsequently carried out to provide the desired isoquinolone 
with 83% yield.38 
 
Scheme 34. The scope of the in situ DIB-catalyzed oxidative annulation.38 
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Scheme 35. Proposed mechanism of in situ DIB-catalyzed oxidative annulation of benzamide.38 
The oxidative dearomatizing cycloaddition induced by different trivalent iodine 
compounds was studied by Canesi and co-workers in 2013 (Scheme 35). The use of polar 
and non-nucleophilic solvents such as HFIP and TFE as well as the presence of a sulfonyl 
moiety on the lateral chain of substrates was necessary to stabilize the electrophilic 
species generated during the hypervalent iodine-mediated umpolung activation (Scheme 
36).39  
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Scheme 36. Studies on optimization and substrate scope for iodine (III)-catalyzed oxidative 
dearomatizing cycloaddition.39 
 
Scheme 37. Structures of electrophilic species generated by aromatic ring umpolung process39 
Previously, Canesi et al. also reported the DIB-mediated cycloaddition of substituted 
phenols with sufficiently reactive alkenes to obtain various heterocyclic compounds such 
as dihydrofuranobenzofurans, tetrahydrofuranobenzofurans, 
tetrahydropyranopyranofurans, and dihyrobenzofurans (Scheme 37). Similar to the above 
oxidative dearomatizing cycloaddition, the hypervalent iodine catalyst induced an 
umpolung activation to convert an electron-rich substituted phenol to a reactive 
electrophilic intermediate which was subsequently attacked by an alkene to give the 
corresponding cycloadduct after consecutive steps (Scheme 38).40 
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Scheme 38. Proposed mechanism of DIB-mediated cycloaddition of substituted phenol with 
furan.40 
 
Scheme 39. Reaction scope of DIB-catalyzed cycloaddition of substituted phenols with different 
reactive alkenes.40 
In 2015, Afonso and co-workers developed a DIB-catalyzed process to synthesize β-
lactams in a single step which was much more convenient compared to the previous two-
stepped process involving using transition metal catalysts and toxic, carcinogenic, and 
potentially explosive diazo compounds. The study on reaction mechanism by ESI-HRMS 
technique revealed the reaction undergoes the formation of intermediate iodonium ylides 
(mass: 467) which then intramolecularly cyclized to produce the corresponding 
products.41 
34 
 
 
Scheme 40. DIB-mediated synthesis of β-lactams via C-H insertion.41 
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As a part of an effort to prepare some potent antinociceptive analogues from 
mitragynine, a major constituent of Mitragyna speciosa, Takayama and co-workers 
developed an efficient method for protection-deprotection of 2,3-π bonds of indoles. The 
protecting process was performed under a mild condition (0 oC, 1.5 h) under the catalysis 
of PIFA to afford the 2,3-ethylene glycol bridged adducts in quantitative yields.42, 43 
 
Scheme 41. The protection-deprotection of 2,3-π bonds of mitragynine.42, 43 
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3. RESULTS AND DISCUSSION 
3.1. The aim of research 
The aim of this research is to prepare some 1,2,4-oxadiazoles and pyrrolo-isoxazoles 
by the hypervalent iodine-mediated cycloaddition of in situ generated nitrile oxides to 
nitriles or maleimides. The hypervalent iodine species 2-
[hydroxy(trifluoromethanesufonyloxy)]-iodobenzoic acid (IBA-OTf) was used in a 
catalytic amount to oxidize the starting material aldoximes into corresponding nitrile 
oxides. The cheap terminal oxidant m-CPBA and the additive TfOH acting as a ligand 
source were introduced to the reaction mixture in stoichiometric quantity to continuously 
transform a given monovalent iodine pre-catalyst 2-iodobenzoic acid into the active IBA-
OTf in a catalytic cycle. 
 
Scheme 42. IBA-OTf-mediated oxidative cyclization of aldoximes with nitriles and maleimides 
in catalytic condition. 
3.2. Structural study and reaction scope of IBA-OTf 
In previous research published in 2015, we reported the preparation, structural 
identification, and oxidative reactivity towards various organic substrates of IBA-OTf, a 
novel iodine (III) species, which is easily prepared from the 2-iodosylbenzoic acid (IBA) 
and TfOH.44 The pseudocyclic square-planar structure of IBA-OTf was confirmed by X-
ray crystallography showing the presence of two long weak bonds established by the 
intramolecular iodine–carbonyl oxygen interaction and intermolecular iodine–triflate 
oxygen (Figure 5). This structure provides a reasonable explanation for the increased 
thermal stability and solubility in common organic solvents of IBA-OTf compared to 
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IBA and iodosylbenzene. Further structural study of IBA-OTf by positive electrospray 
ionization mass spectrometry (ESI-MS) recorded in methanol demonstrated the presence 
of molecular cation [C6H4CO2HIOH]
+ at m/z 265. Additionally, other cations generated 
from ligand-exchange reaction with methanol (m/z 279) and dimerization (m/z 525) were 
also observed in the ESI-MS spectrum. 
 
Figure 5. X-ray crystal structure of IBA-OTf and its intermolecular interaction in crystalline 
state.44 
 
Figure 6. ESI-Mass spectrum of IBA-OTf in methanol solvent.44 
IBA-OTf was then tested for its oxidizing performance on a variety of organic 
substrates to afford the corresponding oxidatively functionalized products in moderate to 
good yields under mild conditions (Scheme 43). As expected, a stoichiometric amount of 
IBA-OTf (1-1.6 equiv) was required for a quantitative conversion. Further studies on 
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oxidative cyclization of different aldoximes with nitriles showed that this trivalent iodine 
species exhibited an excellent performance to induce the quantitative generation of 
corresponding nitrile oxides which then undergoes the cyclization with nitriles to give 
desired 1,2,4-oxadiazoles in good yields up to 91% (Table 1).44 Such promising results 
encouraged us to develop a novel procedure for the synthesis of analogous oxadiazoles 
under catalytic conditions as presented in latter sections. 
Table 1. Oxidative cycloaddition of aldoximes with nitriles using IBA-OTf.a, b 
 
 
a Reagents and conditions: aldoximes (0.125 mmol) and IBA-OTf (0.15 mmol) in appropriate 
nitrile solvent (1 mL) at room temperature for 1 h. b Isolated yields. c Unprotected phenolic 
oxadiazole was also isolated in 9% as a by-product. 
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Scheme 43. The preparation and synthetic versatility of IBA-OTf in oxidative functionalization.44 
3.3. IBA-OTf mediated formation of 1,2,4-oxadiazoles in catalytic condition 
3.3.1. Optimization study 
In the continuation of our research on the reactivity of IBA-OTf under catalytic 
conditions, we report herein the IBA-OTf-catalyzed formation of 1,2,4-oxadiazoles by 
the cycloaddition of aldoximes to nitriles. In this procedure, a cycle consisting of the 
generation of IBA-OTf from 2-iodobenzene in the presence of a terminal oxidant and 
TfOH and the oxidation of aldoximes by IBA-OTf to afford nitrile oxides and regenerate 
2-iodobenzoic acid was repeated many times until all substrate was consumed. The in situ 
unstable nitrile oxides were then immediately captured by nitriles through 1,3-dipolar 
cycloaddition to produce desired 1,2,4-oxadiazoles. 
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Table 2. Optimization study for the hypervalent iodine-mediated cyclization of benzaldoxime 
with acetonitrile. 
 
Entry 
Temp. (oC), 
time (h) 
ArI (equiv.) Oxidant (equiv.) Acid (equiv.) 3a (%)a 
1 r.t., 24 2a (0.5) m-CPBA (2.0) TfOH (1.2) 86 
2 r.t., 24  2a (0.5) m-CPBA (2.0) TfOH (none) 3 
3 r.t., 24 2a (0.2) m-CPBA (2.0) TfOH (1.2) 86 
4 r.t., 24 2a (0.1) m-CPBA (2.0) TfOH (1.2) 90 
5 r.t., 24 2a (0.05) m-CPBA (2.0) TfOH (1.2) 86 
6 r.t., 24 2a (0.025) m-CPBA (2.0) TfOH (1.2) 70 
7 r.t., 24 2a (0.010) m-CPBA (2.0) TfOH (1.2) 76 
8 r.t, 24 2a (none) m-CPBA (2.0) TfOH (1.2) 3 
9 r.t., 24 2a (0.05) m-CPBA (1.5) TfOH (1.2) 86 
10 r.t., 24 2a (0.05) m-CPBA (1.2) TfOH (1.2) 87 (83) 
11b r.t., 24 2a (0.05) m-CPBA (1.2) TfOH (1.2) 54 
12 r.t., 6 2a (0.05) m-CPBA (1.2) TfOH (1.2) 76 
13 r.t., 3 2a (0.05) m-CPBA (1.2) TfOH (1.2) 73 
14 r.t., 1 2a (0.05) m-CPBA (1.2) TfOH (1.2) 44 
15 r.t., 24 2b (0.05) m-CPBA (1.2) TfOH (1.2) 77 
16 r.t., 24 2c (0.05) m-CPBA (1.2) TfOH (1.2) 81 
17 r.t., 24 2d (0.05) m-CPBA (1.2) TfOH (1.2) 74 
18 r.t., 24 2e (0.05) m-CPBA (1.2) TfOH (1.2) 81 
19 r.t., 24 2f (0.05) m-CPBA (1.2) TfOH (1.2) 76 
20 r.t., 24 2g (0.05) m-CPBA (1.2) TfOH (1.2) 73 
21 r.t., 24 2a (0.05) Oxone (1.2) TfOH (1.2) 23 
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22 r.t., 24 2a (0.05) 70% TBHP (1.2) TfOH (1.2) 1 
23 r.t., 24 2a (0.05) 30% H2O2 (1.2) TfOH (1.2) 1 
24 r.t., 24 2a (0.05) m-CPBA (1.2) H2SO4 (1.2) 10 
25 r.t., 24 2a (0.05) m-CPBA (1.2) p-TsOH (1.2) 6 
26 r.t., 24 2a (0.05) m-CPBA (1.2) TFA (1.2) 3 
27 r.t., 24 2a (0.05) m-CPBA (1.2) AcOH (1.2) 7 
a Yields are calculated from 1H NMR spectra of reaction mixtures using 1,1,2,2-
tetrachloroethane as internal standard (numbers in parentheses are reported as isolated yields). 
b Dichloromethane solution of 10 equivalents of MeCN was employed instead of MeCN 
solvent. 
 
First, optimization studies were conducted on the model reaction between 
benzaldoxime 1a and acetonitrile. It can be seen from the Table 2 that at least 5 mol% of 
2a was required for a quantitative transformation to furnish the desired product 3a in the 
best yields from 86 to 90% (entry 1, 3-5). Only a trace amount of 3a (3%) was detected 
while 83% of starting material 1a was recovered when the reaction was performed in the 
absence of iodine resource 2a (entry 8). 
Reducing the quantity of m-CPBA down to 1.2 equiv. did not result in any variation 
in the yield of 3a (entry 5, 9, and 10). This result is in agreement with the proposed 
mechanism in which only an equivalent amount of terminal oxidant is expected to be 
sufficient for a complete conversion of aldoximes into corresponding nitrile oxides. The 
reaction was then performed in dichloromethane solution containing 10 equiv. of MeCN 
to give 3a in a moderate yield of 54% (entry 11) which is much lower than those carried 
out in MeCN as a solvent. Decreasing the reaction time from 24 h to 1 h while keeping 
other experimental parameters constant reduced the yield of 3a from 87% to 44% (entry 
10 and 14). Varying the reaction time within the interval from 3h to 6 h did not lead to 
any significant change in reaction yield (entry 12 and 13). 
A study on the structure-reactivity relationship of iodoarenes revealed that except 2a 
exhibiting the unusual pre-catalytic activity to produce 3a, there was no much difference 
in reactivity for the remaining iodoarenes 2b-g (entry 15-20). The reactivity of other 
terminal oxidants was also investigated, and the results showed that except a low yield of 
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3a (23%, entry 21) observed for oxone, only trace amounts of 3a (1%, entry 22 and 23) 
were obtained in the presence of TBHP or H2O2. In a similar way, replacing TfOH by 
other acidic ligands including H2SO4, p-TsOH, TFA, and AcOH resulted in the negligible 
formation of 3a with the NMR yields ranging from 3% to 10%. Generally, it can be 
easily concluded that the reaction was partially controlled by the acidity of the ligands 
when TfOH which is about 1000 times stronger than H2SO4 afforded the cycloadduct 3a 
in much higher yield than other acidic ligands. However, unfortunately, for the rest of 
investigated acidic ligands, it is hard to make a comparison on their reactivity due to a 
minor difference in yield of 3a (entry 24-27). 
3.3.2. Substrate scope study  
The optimized conditions were then applied for the preparation of a variety of 
substituted 1,2,4-oxadiazoles, and the results are presented in Table 3. In general, under 
appropriate conditions, the substrates bearing either electron-withdrawing or electron-
donating substituents can effectively react with nitriles to form the corresponding 1,2,4-
oxadiazoles in good isolated yields. However, for those containing strongly electron-
withdrawing groups such as 1h, 1i, and 1k, a slight decrease in isolated yields of 
corresponding substituted 1,2,4-oxadiazoles was recorded. These results will make sense 
if the effect of substituents on the contribution of different resonance structures of nitrile 
oxides is taken into consideration. 
It is commonly known that nitrile oxides are represented in five resonance forms 
among which A and B are those whose contributions are the most notable (Figure 7). We 
believe that the cycloaddition of nitrile oxides with a typical asymmetric dipolarophile 
like acetonitrile can be more favored if the resonance structure A is involved in the 
concerted pericyclic cycloaddition step. In this transition state, it is easy for acetonitrile to 
approach towards nitrile oxides in the manner in which the electrostatic interaction 
between the dipole of acetonitrile and nitrile oxides is reinforced. On the other hand, the 
nucleophilic attack of acetonitrile to the resonance form B is not favored due to the 
repulsive electrostatic force between the dipole of acetonitrile and nitrile oxides (Figure 
8). The contribution of resonance structure B, in turn, is more significant for nitrile 
oxides generated from aldoximes bearing strongly electron-withdrawing groups such as -
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CN (1h), -NO2 (1i), and -CO2Me (1k) which can effectively delocalize the negative 
charge on carbon center by resonance effect. As a result, their reactivity in pericyclic 
addition with acetonitrile is diminished due to the lessening contribution of resonance 
structure A and a drop of about 10% in isolated yield was observed for these substrates. 
 
Figure 7. Different resonance structures of nitrile oxides. 
 
Figure 8. Proposed electrostatic interaction in the transition states of the pericyclic cycloaddition 
between nitrile oxide and acetonitrile. 
The cycloadditions of nitrile oximes derived from typical aliphatic or α,β-unsaturated 
aldoximes, hydrocinnamaldehyde oxime 1l and cinnamaldehyde oxime 1m, respectively, 
with acetonitrile afforded the corresponding products in moderate yields. For the starting 
material 1j bearing a susceptible acetoxy substituent, the deacylated phenolic oxadiazole 
3j’ instead of the expected one 3j was formed in the majority with an isolated yield of 
56%. Further stirring of the reaction mixture in the presence of an additional amount of 
TfOH for 48 h resulted in the formation of 3j’ as the only product in 70% isolated yield. 
Interestingly, a trivially modified procedure where the amounts of m-CPBA and TfOH 
were both adjusted to 3 equivalents with respect to the substrate terephthalaldehyde 
dioxime 1n was successfully employed to prepare dicycloadduct 3n in a good isolated 
yield of 88%. 
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Scheme 44. One-pot synthesis of phenolic oxadiazole. 
Table 3. Study on reactant scope of oxidative cyclization of aldoximes with nitriles using 
catalytic IBA-OTf.a 
 
 
a Isolated yields. e The corresponding deacylated phenolic 3j’ was also isolated in 56% yield. 
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We then investigated the reaction scope of various nitriles bearing different 
substituents such as ethyl (1o), isopropyl (1p), trichloromethyl (1q), and phenyl (1r). At 
first glance, it seemed that this cycloaddition was apparently governed by the electronic 
effects of nitriles when the presence of a typical electron withdrawing substituent such as 
trichloromethyl drastically reduced the isolated yield of corresponding product 3q down 
to 18%. However, it should be known from the viewpoint of frontier molecular orbital 
theory (FMO) that both electron-rich and electron-poor dipolarophiles can accelerate the 
reaction to give the desired cycloadducts in high yields. According to this theory, the 1,3-
cycloaddition of nitrile oxides is classified in type II where the bond formation in 
transition states can be achieved by one of two following mechanisms: i) the overlap 
between the HOMO of dipolarophile and the LUMO of nitrile oxide; ii) the overlap 
between the LUMO of dipolarophile and the HOMO of nitrile oxide (Figure 9). For a 
given dipolarophile, it is known that an electron-withdrawing group would lower the 
energy of MOs while an electron-donating group would raise the energy of MOs in the 
dipolarophile. The energy gap between two interacting MOs in dipole (nitrile oxide) and 
dipolarophile (nitrile) therefore is reduced in both cases, accounting for the increasing 
reactivity observed for both electron-rich and electron-poor dipolarophiles. The steric 
effect of trichloromethyl moiety should be taken into consideration to explain the 
exceptional poor yield of 3q.   
 
Figure 9. Sustmann’s classification of 1,3-dipolar cycloadditions. 
3.3.3. Studies on structural characterization of in situ hypervalent iodine species and 
reaction mechanism 
Further study on the structural properties of active hypervalent iodine species present 
in the catalytic system was conducted with the help of ESI/HR-MS and NMR techniques. 
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It was indicated that both hydroxy(aryl)iodonium salt (M+ = 264.9369) and its dimeric 
form (M+ = 510.8551) were simultaneously generated in the reaction mixture. In addition 
to spectroscopic and spectrometric analyses, single crystal X-ray crystallographic 
technique was also employed to confirm the structure of both hypervalent iodine species. 
As mentioned above, the monomeric hydroxy(aryl)iodonium was isolated in the form of 
triflate salt. Similarly, dimeric species which was able to be isolated from the solution by 
slow evaporation was also identified as the triflate salt co-crystallized with acetonitrile 
solvent. 
 
Figure 10. The formation of dimeric hypervalent iodine species from IBA-OTf, its X-ray crystal 
structure with triflate anion and the solvent acetonitrile molecule (A) and its intermolecular 
interaction motif in the crystal (B). 
Technically, two forms of hypervalent iodine species can be obtained from the m-
CPBA-mediated oxidation of 2-iodobenzoic acid 2a. Without TfOH, only monomeric 
species was formed in a trace amount which can be only detected from ESI-MS 
(264.9335). The cycloaddition in the absence of TfOH, therefore, only afforded the 
cycloadduct 3a in very poor NMR yield of 3% (entry 2, Table 2). However, the 
generation of active hydroxy(aryl)iodonium species was significantly accelerated by 
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adding a stoichiometric amount of TfOH to the in-process reaction mixture of 2a and m-
CPBA in CD3CN. After one further hour of stirring at room temperature, the monomeric 
and dimeric active hydroxy(aryl)iodonium species were formed in quantitative amounts 
which can be easily seen from ESI-Mass as well as NMR spectroscopy (Scheme 45 and 
46). 
 
Scheme 45. Structural study of active hypervalent iodine species in solvent CH3CN by ESI-MS 
spectrometry. 
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Scheme 46. Structural study of active hypervalent iodine species in solvent CD3CN by NMR 
spectroscopy. 
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Based on the structural study of in situ IBA-OTf as well as previously reported 
research on similar cycloadditions of aldoximes using other hypervalent iodine reagents, 
we proposed herein the catalytic reaction mechanism as depicted in Scheme 47. The 
active monomeric hydroxy(aryl)iodonium salts (and possibly dimeric form), which are 
catalytically generated from 2-iodobenzoic acid 2a and m-CBPA in the presence of 
TfOH, undergo the redox reaction with aldoximes to produce the corresponding nitrile 
oxides and recovered 2-iodobenzoic acid 2a. The consecutive pericyclic cycloaddition 
between freshly generated nitrile oxides and nitriles as trapping agents to furnish the 
isolable 1,2,4-oxadiazoles. The in situ recovered 2-iodobenzoic acid 2a can be reoxidized 
to active hypervalent iodine species for the next catalytic cycle. 
 
Scheme 47. Proposed mechanism for the catalytic formation of 1,2,4-oxadiazoles.  
3.4. IBA-OTf mediated formation of pyrrolo-isoxazoles in catalytic condition 
3.4.1. Optimization study 
The oxidative performance of IBA-OTf was tested on the cycloaddition of 
benzaldoxime 1a to maleimide 4a to form pyrrolo-isoxazole adduct 5a whose best NMR 
yield was up to 100% when 5 equiv of 4a was added to the reaction mixture. The attempt 
to obtain 5a in quantitative yield with a lower equivalent of 4a was unsuccessful. 
Although no starting material 1a was detected in the resulting mixture after the reaction, 
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only 41-61% recovery of the desired product was recorded (Scheme 46). Further analyses 
on the aqueous solution obtained after work-up steps revealed the presence of benzoic 
acid as the main by-product whose composition was 40% and 37% when 1.5 and 2.5 
equivalent of 4a were added to the reaction mixture, respectively.  
 
Scheme 48. Non-catalytic oxidative cycloaddition of benzaldoxime to maleimide using IBA-OTf 
as the oxidant. 
The formation of pyrrolo-isoxazole 5a deriving from benzaldoxime 1a was then also 
used as the model reaction in the search for optimal conditions of catalytic oxidative 
cycloaddition (Table 4). The fact that no reaction was observed in the absence of 
iodoarene 2a confirmed the necessity of hypervalent iodine species (entry 1). Even a 
small amount of 5-10 mol% of 2a can induce a quantitative conversion of 1a to 5a whose 
NMR yield was over 80% (entry 2 and 3). Interestingly, the reaction can occur without 
TfOH (entry 4) to give 5a in 72% NMR yield because of the presence of some in situ 
hypervalent iodine species generated from the oxidation of 2a by m-CPBA, such as IBA 
and IBA-m-CBA. However, a gradual decrease in yield of 5a was unavoidable when the 
equivalent of TfOH was reduced from 1.2 to none (entry 3-5). In a similar way to the 
non-catalytic procedure, using less than 5 equivalent of 4a also resulted in moderate 
yields of 5a (entry 7 and 8). The study on the pre-catalytic performance of various 
iodoarenes indicated that both 2a and 2b are the most active species which can afford 5a 
in the isolated yields of 85 and 88%, respectively. Iodoarene 2a was then chosen for the 
following study on substrate scope due to its less costly commercial availability. A 
subsequent solvent scope study was performed on a variety of polar and nonpolar 
solvents. It was apparently concluded that the reaction was favored in moderately polar 
solvents such as dichloromethane, chloroform, 1,1,2,2-tetrachloroethane, and ethyl 
acetate to give the adduct 5a in excellent NMR yields of over 95% (entry 3, 15-17) while 
a typical non-polar solvent as hexane resulted in a significantly lessened yield of 5a 
(entry 18). The reaction in methanol, however, only furnished a trace amount of desired 
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product 5a because of the competitive esterification of methanol by benzoic acid to form 
methyl benzoate as the main product (entry 19). 
Table 4. Optimization study for the hypervalent iodine-mediated cyclization of benzaldoxime 
with maleimide. 
 
 Entry Solvent 
4a 
(equiv.) 
ArI (equiv.) 
m-CPBA 
(equiv.) 
TfOH 
(equiv.) 
5a (%)a 
1 CH2Cl2 5.0 none 1.5 1.2 none 
2 CH2Cl2 5.0 2a (0.05) 1.5 1.2 86 
3 CH2Cl2 5.0 2a (0.1) 1.5 1.2 100 (85) 
4 CH2Cl2 5.0 2a (0.1) 1.5 0.6 93 
5 CH2Cl2 5.0 2a (0.1) 1.5 none 72 
6 CH2Cl2 5.0 2a (0.1) 1.2 0.6 80 
7 CH2Cl2 2.5 2a (0.1) 1.5 1.2 59 
8 CH2Cl2 1.5 2a (0.1) 1.5 1.2 54 
9 CH2Cl2 5.0 2b (0.1) 1.5 1.2 100 (88) 
10 CH2Cl2 5.0 2c (0.1) 1.5 1.2 78 
11 CH2Cl2 5.0 2h (0.1) 1.5 1.2 85 
12 CH2Cl2 5.0 2e (0.1) 1.5 1.2 95 
13 CH2Cl2 5.0 2f (0.1) 1.5 1.2 95 
14 CH2Cl2 5.0 2g (0.1) 1.5 1.2 75 
15 (CHCl2)2 5.0 2a (0.1) 1.5 1.2 96 (82) 
16 CHCl3 5.0 2a (0.1) 1.5 1.2 95 
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17 EtOAc 5.0 2a (0.1) 1.5 1.2 95 
18 n-Heptane 5.0 2a (0.1) 1.5 1.2 66 
19 MeOH 5.0 2a (0.1) 1.5 1.2 Trace 
a Yields are calculated from 1H NMR spectra of reaction mixtures using 1,1,2,2-
tetrachloroethane as internal standard (numbers in parentheses are reported as isolated yields). 
 
3.4.2. Substrate scope and reaction mechanism study  
It can be seen from the Table 5 that the reaction of aromatic aldoximes bearing 
electron-withdrawing or electron-donating substituents in general afforded the 
corresponding pyrrolo-isoxazole adducts in good yields (85-98%). These results make 
sense when the stabilization of in situ generated nitrile oxides by electrostatic interactions 
is counted as a critical factor deciding the reaction yield. As mentioned previously in the 
introduction section, the presence of electron-withdrawing or electron-donating 
substituents, especially those in the para position of the benzene ring, is essential for the 
stabilization of nitrile oxide via inductive or resonance effect-induced delocalization of 
the positive as well as negative charge of the carbon in nitrile oxide moiety. The only 
exceptional low yield of 5b (43%) can be explained based on the fact that the methyl 
group or electron-rich aromatic ring was oxidized in competition with cycloaddition to 
produce water-soluble by-products which were not recovered after the treatment with 
NaHCO3 solution during the work-up step. Likewise, the assumption that carbon-carbon 
double is probably oxidized under the investigated reaction conditions can also be 
applicable to explain the slightly weak reactivity of 1m towards cycloaddition when the 
desired adduct 5m was only achieved in a fair isolated yield of 70%. Interestingly, in 
spite of the presence of O-substituted bulky chlorine group in 1e and 1f, the 
corresponding cycloadducts 5e and 5f were still isolated in good yields of 87% and 95%, 
respectively. This result is presumably due to the domination of electrostatic effect over 
steric effect.  
As expected, the nitrile oxide generated from aliphatic aldoxime 1l was unstable 
because of the lack of extended conjugation. As a result, the localized charge on the 
nitrile oxide functional group made this species overreactive and quickly destroyed 
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before reacting with maleimide to give the desired product 5l in a poor yield (31%). 
Furthermore, the fact that the acidic methylene moiety adjacent to the benzene ring is 
likely suffered from competitive oxidation was also considered as the secondary factor 
contributing to the extremely low yield of 5l. 
Table 5. Study on reactant scope of oxidative cyclization of aldoximes with maleimide using 
catalytic IBA-OTf.a, b 
 
 
a Reagents and conditions: aldoximes (0.250 mmol), maleimide 4a or 4b (1.250 mmol), m-
CPBA (0.375), TfOH (0.300 mmol), and 2-iodobenzoic acid (0.025 mmol) in dichloromethane 
(2 mL) at room temperature for 24 h. b Isolated yields. 
 
Additionally, some control experiments were also performed to study the mechanism 
of the [3+2] catalytic cycloaddition of benzaldoximes with maleimide in particular and 
other dipolarophiles in general. In the proposed mechanism, the generation of nitrile 
oxides from benzaldoximes was depicted as a two-step process consisting the ligand 
exchange and oxidation step. The existence of the ligand exchange step can be verified 
by the reaction of maleimide 4a with the protected benzaldoxime, O-
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methylbenzaldoxime. The fact that no cycloadduct 5a was detected under the optimized 
conditions straightforwardly demonstrated the requirement of the ligand exchange step to 
initiate the formation of nitrile oxides. In a similar way, the second control reaction 
between maleimide 4a and acetophenone oxime was performed to test the necessity of 
the oxidation step. Only trace amount of the cycloadduct 5a was detected while unreacted 
starting material, along with the by-product acetophenone, was recovered from the 
reaction mixture in quantitative yields. This results indicated that oxidation step also 
played a major role in the formation of nitrile oxides. 
 
Scheme 49. Proposed mechanism for IBA-OTf assisted generation of nitrile oxide through a two-
step process of ligand exchange and oxidation-reductive elimination and blank experiments for 
confirmation.   
Further study on mechanism showed that this reaction was induced by the active 
hydroxy(aryl)iodonium species generated from the m-CPBA-mediated oxidation of 2-
iodobenzoic acid 2a. Without TfOH, this active species was formed in a trace amount 
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which can be only detected by ESI-Mass spectroscopy (264.9335). The cycloaddition, 
therefore, was still able to proceed in the absence of TfOH to afford the pyrrolo-isoxazole 
5a in a fair NMR yield of 72% (entry 5, Table 4). However, the generation of active 
hydroxy(aryl)iodonium species was significantly accelerated by adding a stoichiometric 
amount of TfOH to the in-process reaction mixture of 2a and m-CPBA in CH2Cl2. After 
one further hour of stirring at room temperature, the active hydroxy(aryl)iodonium 
species was formed in a quantitative amount which can be easily seen from ESI-MS as 
well as NMR spectroscopy. As expected, the catalytic cycloaddition in the presence of 
TfOH as an additive can approach the completion to give the pyrrolo-isoxazole 5a in 
excellent NMR yield of 100% (entry 3, Table 4).  
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Scheme 50. Structural study of active hypervalent iodine species in solvent CH2Cl2 by ESI-MS 
spectrometry. 
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Scheme 51. Structural study of active hypervalent iodine species in solvent CD2Cl2 by NMR 
spectroscopy. 
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Scheme 52. A plausible mechanism for the catalytic formation of pyrrolo-isoxazoles.  
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4. EXPERIMENTAL SECTION 
4.1. Chemicals and equipment 
 All chemicals and solvents were purchased from Sigma–Aldrich and employed 
without further purification. Silica gel for column chromatography and preparative thin 
layer chromatography plates were from Dynamic Adsorbents Inc. and Analtech, 
respectively. All the reactions were carried out under dry argon atmosphere using 
moisture free glassware. Acetonitrile and dichloromethane which were used as reaction 
media must be freshly distilled from CaH2 before use.   
 Ohaus Adventurer electronic semianalytical balance, model EPB-203. 
 Electrothermal melting point apparatus, model MEL-TEMP 1101D. 
 Eyela rotary evaporator system, model N-1001. 
 Barnstead Thermolyne CIMAREC magnetic stirrer, model S131125 
 Agilent GC system, model 7890A, equipped with a Mass selective detector 
Agilent 5975C VL MSD and a capillary column DB-5MS (60 m x 0.25 mm x 0.3 µm). 
 Perkin-Elmer 1600 series FT-IR. 
 Bruker micrOTOF-Q II HR-MS instrument. 
 Single crystal X-ray diffractometer Rigaku RAPID II Image Plate, equipped with 
a graphite-monochromated MoKα radiation source (λ = 0.71073 Å). 
 Varian Inova 500 NMR spectrometer was used to record all 1H NMR spectra of 
the products at 500 MHz. 
 Varian Mercury 300 NMR spectrometer was used to record all 13C NMR spectra 
of the products at 75 MHz. 
 Welch DuoSeal vacuum pump, model 1399B-01, equipped with a Schlenk line. 
4.2. Typical procedure for the preparation of aldoximes 
A flask (50 mL volume) was charged with a corresponding precursor aldehyde (5 
mmol), hydroxyamine hydrochloride (695 mg, 10 mmol), pyridine (1528 mg, 20 mmol), 
and dichloromethane (25 mL). The reaction mixture was stirred at room temperature for 
20 h. Upon completion, the resulting solution was washed with HCl 10% (15 mL) and 
subsequently with water. The organic layer was dried over anhydrous Na2SO4, filtered, 
and concentrated under reduced pressure to give the crude product. Further purification 
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was performed on column chromatography with silica gel and eluent solvent of 
hexane/ethyl acetate to afford the corresponding oxime as white to yellow solid. 
4.3. Typical procedure and spectral data for the preparation of 1,2,4-oxadiazoles 
Method A: 2-Iodobenzoic acid 2a (3.1 mg, 0.0125 mmol), m-CPBA (52 mg, 0.300 
mmol), and trifluoromethylsulfonic acid (45 mg, 0.300 mmol) were added to a solution of 
aldoxime 1a-c, 1h-m (0.250 mmol) in 2.0 mL of the appropriate nitrile solvent. The 
reaction mixture was stirred at room temperature for 24 h. Upon completion, the reaction 
was quenched by adding 5% aqueous Na2S2O3 (2 mL) and then saturated NaHCO3 (5 
mL). The resulting mixture was then extracted with dichloromethane. The organic 
portion was dried over anhydrous Na2SO4, filtered, and concentrated under reduced 
pressure to give the crude products. Further purification was performed on column 
chromatography with silica gel and eluent solvent of hexane/ethyl acetate to afford the 
corresponding 1,2,4-oxadiazoles as white to yellow solids. 
5-Methyl-3-phenyl-1,2,4-oxadiazole (3a) 
 
Reaction of benzaldehyde oxime 1a (30 mg, 0.25 mmol) and acetonitrile according to 
the general procedure afforded product 3a (33 mg, 83%) as a white solid: mp 38.9 - 39.1 
oC; 1H NMR (500 MHz, TMS, CDCl3): δ (ppm) 8.07-8.05 (m, 2H), 7.50-7.43 (m, 3H), 
2.66 (s, 3H); 13C NMR (75 MHz, TMS, CDCl3): δ (ppm) 176.8, 168.6, 131.3, 129.1, 
127.6, 127.1, 12.6. 
5-Methyl-3-(p-tolyl)-1,2,4-oxadiazole (3b) 
 
Reaction of 4-methylbenzaldehyde oxime 1b (34 mg, 0.25 mmol) and acetonitrile 
according to the general procedure afforded product 3b (37 mg, 84%) as a white solid: 
mp 78.5 - 79.7 °C; 1H NMR (500 MHz, TMS, CDCl3): δ (ppm) 7.95 (d, J = 7.8 Hz, 2H), 
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7.27 (d, J = 7.8 Hz, 2H), 2.65 (s, 3H), 2.41 (s, 3H); 13C NMR (75 MHz, TMS, CDCl3): δ 
(ppm) 176.3, 168.4, 141.4, 129.5, 127.3, 124.0, 21.5, 12.4. 
3-(4-Chlorophenyl)-5-methyl-1,2,4-oxadiazole (3c) 
 
Reaction of 4-chlorobenzaldehyde oxime 1c (38 mg, 0.25 mmol) and acetonitrile 
according to the general procedure afforded product 3c (38 mg, 78%) as a white solid: 
mp 92.8 - 93.9 °C; 1H NMR (500 MHz, CDCl3): δ (ppm) 8.00 (d, J = 8.3 Hz, 2H), 7.46 
(d, J = 8.3 Hz, 2H), 2.66 (s, 3H); 13C NMR (75 MHz, TMS, CDCl3): δ (ppm) 176.7, 
167.6, 137.3, 129.2, 128.7, 125.3, 12.4. 
4-(5-Methyl-1,2,4-oxadiazol-3-yl)benzonitrile (3h) 
 
Reaction of 4-cyanobenzaldehyde oxime 1h (36 mg, 0.25 mmol) and acetonitrile 
according to the general procedure afforded product 3h (34 mg, 74%) as a white solid: 
mp 114.9 - 117.0 °C; IR (CH2Cl2) cm
-1 3077, 3059, 2923, 2853, 2230, 1592, 1557, 1047; 
1H NMR (500 MHz, TMS, CDCl3): δ (ppm) 8.19 (d, J = 8.3 Hz, 2H), 7.78 (d, J = 8.3 Hz, 
2H), 2.69 (s, 3H); 13C NMR (75 MHz, TMS, CDCl3): δ (ppm) 177.3, 167.1, 132.6, 131.0, 
127.9, 118.2, 114.7, 12.4. HR-MS (ESI-APSI-negative ionization): calcd for C10H7N3O 
([M]+): 185.0589, found: 185.0588. 
5-Methyl-3-(4-nitrophenyl)-1,2,4-oxadiazole (3i) 
 
Reaction of 4-nitrobenzaldehyde oxime 1i (42 mg, 0.25 mmol) and acetonitrile 
according to the general procedure afforded product 3i (34 mg, 67%) as a white solid: mp 
145.0 - 146.8 °C; IR (CH2Cl2) cm
-1 3099, 2923, 2853, 1520, 1349, 1049; 1H NMR (500 
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MHz, TMS, CDCl3): δ (ppm) 8.34 (d, J = 7.0 Hz, 2H), 8.26 (d, J = 7.0 Hz, 2H), 2.70 (s, 
3H); 13C NMR (75 MHz, TMS, CDCl3) δ (ppm) 177.4, 166.9, 149.4, 132.7, 128.3, 124.1, 
12.4. 
4-(5-Methyl-1,2,4-oxadiazol-3-yl)phenyl acetate (3j) 
 
Reaction of 4-(hydroxyimino)methyl-phenyl acetate 1j (44 mg, 0.25 mmol) and 
acetonitrile according to the general procedure afforded product 3j (17 mg,  31%) and 
deacylated product 3j’ (25 mg, 56%). The product 3j was isolated as a white solid: mp 
115.5 - 117.4 °C; IR (CH2Cl2) cm
-1 3007, 2927, 2862, 1756, 1540, 1217, 1047; 1H NMR 
(500 MHz, TMS, CDCl3): δ (ppm) 8.09 (d, J = 8.5 Hz, 2H), 7.22 (d, J = 8.5 Hz, 2H), 
2.65 (s, 3H), 2.33 (s, 3H); 13C NMR (75 MHz, TMS, CDCl3): δ (ppm) 176.6, 169.1, 
167.7, 152.8, 128.7, 124.5, 122.1, 21.2, 12.4. 
4-(5-Methyl-1,2,4-oxadiazol-3-yl)phenol (3j’) 
 
The product 3j’ was isolated as a white solid: mp 188.4 - 190.0 °C; IR (CH2Cl2) cm-1 
3424, 2923, 2857, 1540, 1047; 1H NMR (500 MHz, TMS, CDCl3): δ (ppm) 7.85 (d, J = 
9.0 Hz, 2H), 6.88 (d, J = 9.0 Hz, 2H), 2.61 (s, 3H); 13C NMR (75 MHz, TMS, CDCl3): δ 
(ppm) 176.9, 168.0, 160.3, 128.6, 117.6, 115.3, 10.6. 
Methyl 4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoate (3k) 
 
Reaction of methyl-4-(hydroxyimino)methylbenzoate 1k (44 mg, 0.25 mmol) and 
acetonitrile according to the general procedure afforded product 3k (40 mg,  73%) as a 
white solid: mp 164.8 - 165.5 °C; IR (CH2Cl2) cm
-1 3015, 2923, 2857, 1717, 1700, 1538, 
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1279, 1049; 1H NMR (500 MHz, TMS, CDCl3): δ (ppm) 8.14 (s, 4H), 3.95 (s, 3H), 2.68 
(s, 3H); 13C NMR (75 MHz, TMS, CDCl3): δ (ppm) 177.2, 168.0, 166.6, 132.6, 131.1, 
130.3, 127.6, 52.6, 12.6. 
5-Methyl-3-phenethyl-1,2,4-oxadiazole (3l) 
 
Reaction of 3-phenylpropanal oxime 1l (38 mg, 0.25 mmol) and acetonitrile 
according to the general procedure afforded product 3l (33 mg, 70%) as a colorless oil; 
IR (CH2Cl2) cm
-1 3059, 3029, 2928, 2857, 1588, 1456, 1049; 1H NMR (500 MHz, TMS, 
CDCl3): δ (ppm) 7.30 (t, J = 7.3 Hz, 2H), 7.25 - 7.21 (m, 3H), 3.06 – 3.00 (m, 4H), 2.56 
(s, 3H); 13C NMR (75 MHz, TMS, CDCl3): δ (ppm) 176.3, 169.9, 140.3, 128.5, 128.3, 
126.4, 33.0, 27.8, 12.3; HR-MS (ESI-positive ionization): calcd for C11H12N2O 
([M+H]+): 189.1028, found: 189.0998. 
(E)-5-Methyl-3-styryl-1,2,4-oxadiazole (3m) 
 
Reaction of cinnamaldehyde oxime 1m (36 mg, 0.25 mmol) and acetonitrile 
according to the general procedure afforded product 3m (29 mg, 62%) as a white solid: 
mp 79.0 - 80.5 °C; 1H NMR (500 MHz, TMS, CDCl3): δ (ppm) 7.67 (d, J = 16.0 Hz, 1H), 
7.56 (d, J = 7.0 Hz, 2H), 7.43 - 7.33 (m, 3H), 7.05 (d, J = 16.0 Hz, 1H), 2.62 (s, 3H); 13C 
NMR (75 MHz, TMS, CDCl3): δ (ppm) 175.8, 167.9, 138.9, 135.3, 129.4, 128.9, 127.4, 
112.8, 12.3. 
5-Ethyl-3-phenyl-1,2,4-oxadiazole (3o) 
 
Reaction of benzoaldoxime 1a (30 mg, 0.25 mmol) and propionitrile according to the 
general procedure afforded product 3o (30 mg, 70%) as a colorless oil; 1H NMR (500 
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MHz, TMS, CDCl3): δ (ppm) 8.09 - 8.06 (m, 2H), 7.50 - 7.47 (m, 3H), 2.98 (q, J = 7.5 
Hz, 2H), 1.46 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, TMS, CDCl3): δ (ppm) 180.7, 
168.3, 131.0, 128.8, 127.4, 127.0, 20.3, 10.8. 
3,5-Diphenyl-1,2,4-oxadiazole (3r) 
 
Reaction of benzaldoxime 1a (30 mg, 0.25 mmol) and benzonitrile according to the 
general procedure afforded product 3r (35 mg, 63%) as a white solid: mp 108.0-109.5 
°C; 1H NMR (500 MHz, TMS, CDCl3): δ (ppm) 8.23 (d, J = 8.0 Hz, 2H), 8.21 - 8.17 (m, 
2H), 7.61 - 7.51 (m, 6H); 13C NMR (75 MHz, TMS, CDCl3): δ (ppm) 175.9, 169.2, 
133.0, 131.4, 129.3, 129.1, 128.4, 127.8, 127.2, 124.6. 
5-(Methyl-d3)-3-phenyl-1,2,4-oxadiazole (3s) 
 
Reaction of benzaldoxime 1a (30 mg, 0.25 mmol) and acetonitrile-d3 according to the 
general procedure afforded product 3s (18 mg, 44%) as a yellow liquid; 1H NMR (500 
MHz, TMS, CDCl3): δ (ppm) 8.08 - 8.06 (m, 2H), 7.52 - 7.46 (m, 3H); 13C NMR (75 
MHz, TMS, CDCl3): δ (ppm) 176.4, 168.4, 131.1, 128.8, 127.3, 126.8, 11.7. 
Method B: 2-Iodobenzoic acid 2a (6.2 mg, 0.025 mmol), m-CPBA (65 mg, 0.375 
mmol), and trifluoromethylsulfonic acid (45 mg, 0.300 mmol) were added to a solution of 
aldoxime 1d-g (0.250 mmol) in 2.0 mL of the appropriate nitrile solvent. The reaction 
mixture was then stirred at room temperature for 24 h. Upon completion, the work-up and 
purification procedure was conducted in a similar way as described in Method A to afford 
the corresponding 1,2,4-oxadiazoles as white to yellow solids. 
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3-(2-Chlorophenyl)-5-methyl-1,2,4-oxadiazole (3d) 
 
Reaction of 2-chlorobenzaldehyde oxime 1d (38 mg, 0.25 mmol) and acetonitrile 
according to the general procedure afforded product 3d (40 mg, 82%) as a yellow oil; IR 
(neat) cm-1 2927, 2857, 1558, 1049; 1H NMR (500 MHz, TMS, CDCl3): δ (ppm) 7.89 
(dd, J = 7.8 and 1.8 Hz, 1H), 7.54 (dd, J = 7.8 and 1.3 Hz, 1H), 7.42 (dd, J = 7.8 and 1.8 
Hz, 1H), 2.69 (s, 3H); 13C NMR (75 MHz, TMS, CDCl3): δ (ppm) 176.1, 167.3, 133.4, 
131.6, 131.6, 130.9, 126.9, 126.2, 12.4. 
3-(3-Chlorophenyl)-5-methyl-1,2,4-oxadiazole (3e) 
 
Reaction of 2-chlorobenzaldehyde oxime 1e (38 mg, 0.25 mmol) and acetonitrile 
according to the general procedure afforded product 3e (42 mg, 86%) as colorless 
needles: mp 69.5 - 71.3 °C; IR (CH2Cl2) cm
-1 3064, 2927, 2862, 1558, 1075; 1H NMR 
(500 MHz, TMS, CDCl3): δ (ppm) 8.06 (d, J = 1.5 Hz, 1H), 7.95 (dd, J = 8.0 and 1.5 Hz, 
1H), 7.47 - 7.45 (m, 1H), 7.41 (t, J = 8.0 Hz, 1H), 2.65 (s, 3H); 13C NMR (75 MHz, 
TMS, CDCl3): δ (ppm) 176.8, 167.4, 134.9, 131.1, 130.1, 128.5, 127.4, 125.4, 12.3. 
3-(2,4-Dichlorophenyl)-5-methyl-1,2,4-oxadiazole (3f) 
 
Reaction of 2,4-dichlorobenzaldehyde oxime 1f (48 mg, 0.25 mmol) and acetonitrile 
according to the general procedure afforded product 3f (49 mg, 86%) as a white solid: mp 
99.2 - 99.8 °C; IR (CH2Cl2) cm
-1 3066, 2927, 2853, 1587, 1060; 1H NMR (500 MHz, 
TMS, CDCl3): δ (ppm) 7.87 (d, J = 8.1 Hz, 1H), 7.56 (d, J = 2.1 Hz, 1H), 7.37 (dd, J = 
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8.1 and 1.5 Hz, 1H), 2.68 (s, 3H); 13C NMR (75 MHz, TMS, CDCl3): δ (ppm) 176.5, 
166.8, 137.4, 134.5, 132.6, 131.1, 127.6, 124.9, 12.6. 
3-(4-Bromophenyl)-5-methyl-1,2,4-oxadiazole (3g) 
 
Reaction of 2,4-dichlorobenzaldehyde oxime 1g (50 mg, 0.25 mmol) and acetonitrile 
according to the general procedure afforded product 3g (45 mg, 75%) as a white solid: 
mp 99.1 - 99.9 °C; IR (CH2Cl2) cm
-1 3015, 2919, 2857, 1540, 1049; 1H NMR (500 MHz, 
TMS, CDCl3): δ (ppm) 7.93 (d, J = 7.5 Hz, 2H), 7.62 (d, J = 7.5 Hz, 2H), 2.65 (s, 3H); 
13C NMR (75 MHz, TMS, CDCl3): δ (ppm) 176.8, 167.7, 132.1, 128.8, 125.8, 125.7, 
12.4. 
5-Isopropyl-3-phenyl-1,2,4-oxadiazole (3p) 
 
Reaction of benzoaldoxime 1a (30 mg, 0.25 mmol) and isobutylnitrile according to 
the general procedure afforded product 3p (32 mg, 69%) as a colorless oil; IR (CH2Cl2) 
cm-1 2923, 2857, 1540, 1049; 1H NMR (500 MHz, TMS, CDCl3): δ (ppm) 8.09 - 8.07 (m, 
2H), 7.49 - 7.47 (m, 3H), 3.29 (sept, J = 7.0 Hz, 1H), 1.46 (d, J = 7.0 Hz, 6H); 13C NMR 
(75 MHz, TMS, CDCl3): δ (ppm) 183.9, 168.2, 131.0, 128.8, 127.4, 127.1, 27.6, 20.2. 
3-Phenyl-5-(trichloromethyl)-1,2,4-oxadiazole (3q) 
 
Reaction of benzoaldoxime 1a (30 mg, 0.25 mmol) and 2,2,2-trichloroacetonitrile 
according to the general procedure afforded product 3q (12 mg, 18%) as a colorless oil; 
1H NMR (500 MHz, TMS, CDCl3): δ (ppm) 8.13 (d, J = 7.3 Hz, 2H), 7.58 - 7.51 (m, 
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3H); 13C NMR (75 MHz, TMS, CDCl3): δ (ppm) 174.4, 169.1, 132.0, 129.0, 127.7, 
125.4, 83.5. 
Method C:  
1,4-bis(5-methyl-1,2,4-oxadiazol-3-yl)benzene (3n) 
 
2-Iodobenzoic acid 2a (6.2 mg, 0.025 mmol), m-CPBA (129 mg, 0.750 mmol), and 
trifluoromethylsulfonic acid (45 mg, 0.750 mmol) were added to a solution of 
terephthalaldehyde dioxime (113 mg, 0.250 mmol) in 2.0 mL of acetonitrile. The reaction 
mixture was stirred at room temperature for 24 h. Upon completion, the work-up and 
purification procedure was conducted in a similar way as described in Method A to afford 
1,4-bis(5-methyl-1,2,4-oxadiazol-3-yl)benzene 3n (53 mg, 88%) as a white solid: mp 
220.5 - 225.0 °C; IR (CH2Cl2) cm
-1 2923, 2857, 1538, 1047; 1H NMR (500 MHz, TMS, 
CDCl3): δ (ppm) 8.19 (s, 4H), 2.68 (s, 6H); 13C NMR (75 MHz, TMS, CDCl3): δ (ppm) 
176.8, 167.8, 129.3, 127.8, 12.4. HR-MS (ESI-APCI-positive ionization): calcd for 
C12H10N4O2 ([M+H]
+): 243.0882, found: 243.0883. 
4.4. Typical procedure and spectral data for the preparation of pyrrolo-isoxazoles 
2-Iodobenzoic acid 2a (6.2 mg, 0.025 mmol), maleimide 4a or 4b (1.25 mmol), m-
CPBA (65 mg, 0.375 mmol), and trifluoromethylsulfonic acid (45 mg, 0.300 mmol) were 
added to a solution of aldoxime 1a-m (0.250 mmol) in dichloromethane (2 mL). The 
reaction mixture was stirred at room temperature for 24 h. Upon completion, the reaction 
was quenched by adding 5% aqueous Na2S2O3 (2 mL) and then saturated NaHCO3 (5 
mL). The resulting mixture was then extracted with ethyl acetate. The organic portion 
was dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure to 
give the crude products. Further purification was performed on column chromatography 
with silica gel and eluent solvent of hexane-ethyl acetate (3:1 and then 1:1) to afford the 
corresponding pyrrolo-isoxazoles 5a-n as white to yellow solids. 
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3-Phenyl-3a,6a-dihydro-4H-pyrrolo[3,4-d]isoxazole-4,6(5H)-dione (5a) 
 
Reaction of benzaldoxime 1a (30 mg, 0.250 mmol) and maleimide 4a (121 mg, 1.25 
mmol) according to the general procedure afforded product 5a (46 mg, 85%) as a white 
solid; colorless prisms (recrystallized from methanol); mp 213-215 °C; IR (neat) cm-1 
1733, 1369, 1214; 1H NMR (500 MHz, CD3OD/ DMSO-d6= 20:1): δ (ppm) 7.99-7.97 
(m, 2H), 7.50-7.46 (m, 3H), 5.52 (d, J = 9.5 Hz, 1H), 5.06 (d, J = 9.5 Hz, 1H); 13C NMR 
(75 MHz, CD3OD/ DMSO-d6= 20:1): δ (ppm) 174.5, 173.1, 153.9, 130.8, 128.7, 128.0, 
127.7, 82.6, 56.4. 
3-(p-Tolyl)-3a,6a-dihydro-4H-pyrrolo[3,4-d]isoxazole-4,6(5H)-dione (5b) 
 
Reaction of p-methylbenzaldehyde oxime 1b (34 mg, 0.250 mmol) and maleimide 4a 
(121 mg, 1.25 mmol) according to the general procedure afforded product 5b (25 mg, 
43%) as an orange solid; orange plates (recrystallized from methanol); mp 182-185 °C; 
IR (neat) cm-1 1734, 1336, 1193; 1H NMR (500 MHz, CD3OD): δ (ppm) 7.84 (d, J = 8.5 
Hz, 2H), 7.26 (d, J = 8.5 Hz, 2H), 5.46 (d, J = 9.0 Hz, 1H), 4.98 (d, J = 9.0 Hz, 1H), 2.38 
(s, 3H); 13C NMR (75 MHz, CD3OD): δ (ppm) 174.6, 173.0, 153.6, 141.3, 129.1, 127.9, 
124.7, 82.3, 56.4, 20.3.  
3-(4-Chlorophenyl)-3a,6a-dihydro-4H-pyrrolo[3,4-d]isoxazole-4,6(5H)-dione (5c) 
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Reaction of p-chlorobenzaldehyde oxime 1c (39 mg, 0.250 mmol) and maleimide 4a 
(121 mg, 1.25 mmol) according to the general procedure afforded product 5c (56 mg, 
90%) as a white solid; light yellow prisms (recrystallized from methanol); mp 196-198 
°C; 1H NMR (500 MHz, CD3OD): δ (ppm) 7.94 (d, J = 8.8 Hz, 2H), 7.45 (d, J = 8.8 Hz, 
2H), 5.50 (d, J = 9.5 Hz, 1H), 5.00 (d, J = 9.5 Hz, 1H); 13C NMR (75 MHz, CD3OD): δ 
(ppm) 174.4, 172.9, 152.9, 136.6, 129.4, 128.7, 126.3, 82.8, 56.2. Single crystals of 
product 5c suitable for X-ray crystallographic analysis were obtained by slow 
crystallization from the methanol. X-ray diffraction data for 4c were collected on Rigaku 
RAPID II Image Plate system using graphite-monochromated MoKα radiation (λ = 
0.71073 Å) at 123 K. The structure was solved by the Patterson method (SHELXS 86) 
and refined by full-matrix least-squares refinement on F2 using Crystals for Windows 
program. Crystal data for 5c C11H7ClN2O3: M 250.64, monoclinic, space group P21/n, a 
= 12.4723(4), b = 5.8635(2), c = 14.9153(10) Å, α = 90.00, β = 107.473(8), γ = 90.00 o, V 
= 1040.45(7) Å3, Z = 4, µ = 0.364 mm-1, 5358 reflections measured, 2246 unique (1924 
I > 2.0/s(I)); final R1 = 0.0386, Rw = 0.0986. CCDC-1470155. 
 
3-(3-Chlorophenyl)-3a,6a-dihydro-4H-pyrrolo[3,4-d]isoxazole-4,6(5H)-dione (5d) 
 
Reaction of m-chlorobenzaldehyde oxime 1d (39 mg, 0.250 mmol) and maleimide 4a 
(121 mg, 1.25 mmol) according to the general procedure afforded product 5d (61 mg, 
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98%) as a white solid; light yellow plates (recrystallized from methanol); mp 192-194 °C; 
IR (neat) cm-1 1746, 1351, 1200; 1H NMR (500 MHz, CD3OD): δ (ppm) 7.99 (t, J = 1.5 
Hz, 1H), 7.91 (dt, J = 8.0, 1.5 Hz, 1H), 7.50-7.43 (m, 2H), 5.51 (d, J = 9.5 Hz, 1H), 5.01 
(d, J = 9.5 Hz, 1H); 13C NMR (75 MHz, CD3OD): δ (ppm) 174.0, 172.6, 152.5, 134.4, 
130.3, 129.9, 129.4, 127.4, 126.0, 82.7, 55.8; HR-MS (ESI-negative ionization): calcd for 
C11H7ClN2O3 ([M-H]
-): 249.0067, found: 249.0077. 
3-(2-Chlorophenyl)-3a,6a-dihydro-4H-pyrrolo[3,4-d]isoxazole-4,6(5H)-dione (5e) 
 
Reaction of o-chlorobenzaldehyde oxime 1e (39 mg, 0.250 mmol) and maleimide 4a 
(121 mg, 1.25 mmol) according to the general procedure afforded product 5e (55 mg, 
87%) as a white solid; light yellow plates (recrystallized from methanol); mp 150.0-152.0 
°C; IR (neat) cm-1 1733, 1338, 1185; 1H NMR (500 MHz, CD3OD): δ (ppm) 7.56-7.51 
(m, 2H), 7.47 (dt, J = 7.5, 1.5 Hz, 1H), 7.39 (dt, J = 7.5, 1.5 Hz, 1H), 5.53 (d, J = 9.5 Hz, 
1H), 5.16 (d, J = 9.5 Hz, 1H); 13C NMR (75 MHz, CD3OD): δ (ppm) 174.5, 172.2, 153.1, 
132.8, 131.4, 131.2, 130.2, 126.9, 126.5, 81.9, 57.9; HR-MS (ESI-negative ionization): 
calcd for C11H7ClN2O3 ([M-H]
-): 249.0067, found: 249.0077. 
3-(2,4-Dichlorophenyl)-3a,6a-dihydro-4H-pyrrolo[3,4-d]isoxazole-4,6(5H)-dione (5f) 
 
Reaction of 2,4-dichlorobenzaldehyde oxime 1f (48 mg, 0.250 mmol) and maleimide 
4a (121 mg, 1.25 mmol) according to the general procedure afforded product 5f (68 mg, 
95%) as a light yellow solid; yellow plates (recrystallized from methanol); mp 175-177 
°C; IR (neat) cm-1 1734, 1336, 1187; 1H NMR (500 MHz, CD3OD): δ (ppm) 7.64-7.61 
(m, 2H), 7.45 (dd, J = 9.0, 2.0 Hz, 1H), 5.56 (d, J = 9.5 Hz, 1H), 5.16 (d, J = 9.5 Hz, 1H); 
13C NMR (75 MHz, CD3OD): δ (ppm) 174.5, 172.5, 152.5, 136.9, 134.0, 132.6, 130.2, 
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127.6, 125.6, 82.3, 57.9; HR-MS (ESI-negative ionization): calcd for C11H6Cl2N2O3 ([M-
H]-): 282.9677, found: 282.9684. 
3-(4-Bromophenyl)-3a,6a-dihydro-4H-pyrrolo[3,4-d]isoxazole-4,6(5H)-dione (5g) 
 
Reaction of p-bromobenzaldehyde oxime 1g (50 mg, 0.250 mmol) and maleimide 4a 
(121 mg, 1.25 mmol) according to the general procedure afforded product 5g (63 mg, 
85%) as a white solid; light yellow plates (recrystallized from methanol); mp 206.0-207.0 
°C; IR (neat) cm-1 1730, 1333, 1214; 1H NMR (500 MHz, CD3OD): δ (ppm) 7.87 (d, J = 
8.5 Hz, 2H), 7.60 (d, J = 8.5 Hz, 2H), 5.50 (d, J = 9.5 Hz, 1H), 5.00 (d, J = 9.5 Hz, 1H); 
13C NMR (75 MHz, CD3OD): δ (ppm) 174.4, 172.9, 153.0, 131.8, 129.6, 126.8, 124.9, 
82.8, 56.1; HR-MS (ESI-negative ionization): calcd for C11H7BrN2O3 ([M-H]
-): 
292.9562, found: 292.9558. 
4-(4,6-Dioxo-3a,5,6,6a-tetrahydro-4H-pyrrolo[3,4-d]isoxazol-3-yl)benzonitrile (5h) 
 
Reaction of p-cyanobenzaldehyde oxime 1h (37 mg, 0.250 mmol) and maleimide 4a 
(121 mg, 1.25 mmol) according to the general procedure afforded product 5h (52 mg, 
87%) as a white solid; white needles (recrystallized from methanol); mp 254-256 °C 
(dec); IR (neat) cm-1 1732, 1339, 1217; 1H NMR (500 MHz, CD3OD/ DMSO-d6= 20:1): 
δ (ppm) 8.16 (d, J = 8.3 Hz, 2H), 7.89 (d, J = 8.3 Hz, 2H), 5.26 (d, J = 9.5 Hz, 1H), 5.13 
(d, J = 9.5 Hz, 1H); 13C NMR (75 MHz, CD3OD/ DMSO-d6= 20:1): δ (ppm) 174.2, 
173.3, 153.3, 132.8, 132.2, 128.9, 118.6, 113.9, 83.6, 56.1; HR-MS (ESI-negative 
ionization): calcd for C12H7N3O3 ([M-H]
-): 240.0409, found: 240.0419. 
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3-(4-Nitrophenyl)-3a,6a-dihydro-4H-pyrrolo[3,4-d]isoxazole-4,6(5H)-dione (5i) 
 
Reaction of p-nitrobenzaldehyde oxime 1i (42 mg, 0.250 mmol) and maleimide 4a 
(121 mg, 1.25 mmol) according to the general procedure afforded product 5i (62 mg, 
95%) as a light yellow solid; light yellow needles (recrystallized from methanol); mp 
243-245 °C (dec); IR (neat) cm-1 1733, 1340, 1214; 1H NMR (500 MHz, DMSO-d6): δ 
(ppm) 11.96 (s, 1H), 8.32 (d, J = 9.0 Hz, 2H), 8.13 (d, J = 9.0 Hz, 2H), 5.60 (d, J = 9.3 
Hz, 1H), 5.22 (d, J = 9.3 Hz, 1H); 13C NMR (75 MHz, DMSO-d6): δ (ppm) 174.7, 173.8, 
153.4, 149.1, 134.0, 129.7, 124.5, 83.9, 56.5; HR-MS (ESI-negative ionization): calcd for 
C11H7N3O5 ([M-H]
-): 260.0307, found: 260.0314. 
Methyl 4-(4,6-dioxo-3a,5,6,6a-tetrahydro-4H-pyrrolo[3,4-d]isoxazol-3-yl)benzoate (5k) 
 
Reaction of p-methoxycarbonylbenzaldehyde oxime 1k (45 mg, 0.250 mmol) and 
maleimide 4a (121 mg, 1.25 mmol) according to the general procedure afforded 5k (60 
mg, 95%) as a white solid; colorless prisms (recrystallized from methanol); mp 211-212 
°C; IR (neat) cm-1 1730, 1355, 1279, 1198; 1H NMR (500 MHz, CD3OD/DMSO-d6= 
20:1): δ (ppm) 8.10 (s, 4H), 5.59 (d, J = 9.5 Hz, 1H), 5.12 (d, J = 9.5 Hz, 1H), 3.95 (s, 
3H) ; 13C NMR (75 MHz, CD3OD/ DMSO-d6= 20:1): δ (ppm) 174.2, 173.1, 166.4, 
153.4, 132.0, 131.9, 129.6, 128.2, 83.2, 56.2, 52.0; HR-MS (ESI-negative ionization): 
calcd for C13H10N2O5 ([M-H]
-): 273.0511, found: 273.0522. 
3-Phenethyl-3a,6a-dihydro-4H-pyrrolo[3,4-d]isoxazole-4,6(5H)-dione (5l) 
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Reaction of 3-phenylpropylaldehyde oxime 1l (37 mg, 0.250 mmol) and maleimide 
4a (121 mg, 1.25 mmol) according to the general procedure afforded product 5l (19 mg, 
31%) as a light yellow solid; colorless needles (recrystallized from methanol); IR (neat) 
cm-1 1733, 1340, 1187; 1H NMR (500 MHz, CD3OD): δ (ppm) 7.30-7.17 (m, 5H), 5.26 
(d, J = 9.5 Hz, 1H), 4.40 (d, J = 9.5 Hz, 1H), 3.05-2.99 (m, 1H), 2.96-2.90 (m, 1H), 2.86-
2.79 (m, 1H), 2.75-2.69 (m, 1H); 13C NMR (75 MHz, CD3OD): δ (ppm) 175.2, 173.2, 
155.1, 140.5, 128.4, 128.2, 126.2, 80.7, 58.5, 31.7, 27.9; HR-MS (ESI-negative 
ionization): calcd for C13H12N2O3 ([M-H]
-): 243.0770, found: 243.0769. 
(E)-3-Styryl-3a,6a-dihydro-4H-pyrrolo[3,4-d]isoxazole-4,6(5H)-dione (5m) 
 
Reaction of cinnamaldehyde oxime 1m (18 mg, 0.125 mmol) and maleimide 4a (60 
mg, 0.625 mmol) according to the general procedure afforded product 5m (21 mg, 70%) 
as a white solid; white prisms (recrystallized from methanol); mp 266-268 °C (dec); IR 
(neat) cm-1 1730, 1357, 1210; 1H NMR (500 MHz, CD3OD/ DMSO-d6= 20:1): δ (ppm) 
7.64 (d, J = 8.5 Hz, 2H), 7.56 (d, J = 16.8 Hz, 1H), 7.46-7.44 (m, 2H), 7.41 (t, J = 7.0 Hz, 
2H), 7.11 (d, J = 16.8 Hz, 1H), 5.48 (d, J = 9.0 Hz, 1H), 4.90 (d, J = 9.0 Hz, 1H); 13C 
NMR (75 MHz, CD3OD): δ (ppm) 174.5, 173.3, 154.7, 140.5, 136.1, 129.6, 129.2, 127.5, 
115.2, 82.7, 55.8; HR-MS (ESI-negative ionization): calcd for C13H10N2O3 ([M-H]
-): 
241.0613, found: 241.0626. 
5-Methyl-3-phenyl-3a,6a-dihydro-4H-pyrrolo[3,4-d]isoxazole-4,6(5H)-dione (5n) 
 
Reaction of benzaldoxime 1a (30 mg, 0.250 mmol) and N-methyl maleimide 4b (139 
mg, 1.25 mmol) according to the general procedure afforded product 5m (41 mg, 72%) as 
an orange solid; orange plates (recrystallized from methanol); mp 158-159 °C; IR (neat) 
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cm-1 1717, 1369, 1210; 1H NMR (500 MHz, CD3OD/ DMSO-d6= 20:1): δ (ppm) 8.00 - 
7.99 (m, 2H), 7.52 - 7.49 (m, 3H), 5.57 (d, J = 9.5 Hz, 1H), 5.12 (d, J = 9.5 Hz, 1H); 13C 
NMR (75 MHz, CD3OD/ DMSO-d6= 20:1): δ (ppm) 173.3, 172.2, 153.7, 131.0, 128.9, 
128.2, 127.8, 81.5, 55.4. 
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5. CONCLUSIONS AND RECOMMENDATIONS 
We developed a simple strategy to prepare in total nineteen 1,2,4-oxadiazoles and 
thirteen pyrrolo-isoxazoles through hypervalent iodine-assisted cyclization of 
benzaldoximes with corresponding dipolarophiles (nitriles or maleimides). In this 
procedure, m-CPBA and TfOH were used in stoichiometric amounts as terminal oxidant 
and ligand resource, respectively, to convert the pre-catalyst 2-iodobenzoic acid into the 
active hypervalent iodine species whose pseudo-cyclic structure was determined as the 
triflate salt of hydroxy(aryl)iodonium (IBA-OTf) in the crystal lattice. Further study on 
reaction mechanism showed that the cyclization undergoes via the formation of nitrile 
oxide intermediates whose stability in reaction solution governs their reactivity to the 
cycloaddition with a given dipolarophile. In the agreement with the frontier molecular 
orbital theory, both substrates bearing electron-withdrawing and electron-donating 
substituents reacted smoothly with nitriles or maleimides to afford 1,2,4-oxadiazoles or 
pyrrolo-isoxazoles in good to excellent yields. However, for those containing functional 
groups susceptible to hydrolysis or oxidation, the side reactions can compete against the 
desired cyclization to generate unwanted by-products and lower the isolated yield of 
expected cycloadducts.    
The identity of all compounds was authenticated by 1H NMR and 13C NMR. IR and 
HR-MS were additionally recorded for new compounds. Especially, single X-ray 
diffraction was used to confirm the bicyclic structure of a typical pyrrolo-isoxazoles. 
Furthermore, structural characterization of different possible cationic hypervalent iodine 
species in the reaction solution was also conducted with the help of ESI-MS and NMR 
techniques to support the study on reaction mechanism. 
For future research, pericyclic cycloaddition to different dipolarophiles containing 
unsaturated carbon-carbon and carbon-heteroatom bonds (C≡C, C=N, C=S, C=O, etc.) 
should be studied to evaluate the catalytic activity and synthetic versatility of in situ 
generated IBA-OTf as well as to develop new methods for the synthesis of important 
heterocyclic scaffolds.  
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